BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9885641)

  • 1. [Tumor marker squamous cell carcinoma antigen].
    Lavie O; Neuman M; Zuckerman B; Hornreich G; Beller U
    Harefuah; 1998 Sep; 135(5-6):222-5. PubMed ID: 9885641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Squamous cell carcinoma antigen].
    Nawata S; Sugino N; Kato H
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():684-6. PubMed ID: 16149611
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
    Ievleva ES; Ermoshina NV; Ageenko AI
    Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor markers in uterine cancers].
    Fukasawa I; Kousaka N; Kun Z; Inaba N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer].
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Gynakol Rundsch; 1989; 29 Suppl 2():411-2. PubMed ID: 2613066
    [No Abstract]   [Full Text] [Related]  

  • 6. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
    Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
    Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma antigen.
    Kerawala C
    Oral Oncol; 2006 Jan; 42(1):3-4. PubMed ID: 16140567
    [No Abstract]   [Full Text] [Related]  

  • 8. Squamous cell carcinoma antigen as a biomarker for penile cancer.
    Kommu S; Hadway P; Watkin N
    BJU Int; 2005 Mar; 95(4):478-9. PubMed ID: 15705062
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of SCC antigen assay as a tumor marker].
    Kato H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1057-9. PubMed ID: 2192106
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.
    Meier W; Stieber P; Hasholzner U; Baumgartner L; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2959-62. PubMed ID: 9329575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of squamous cell carcinoma antigen in the blood of patients with cancer of the uterine cervix].
    Tolino A; Di Serio C; Borruto Caracciolo G; Riccio S; Piragine L; Montemagno U
    Minerva Ginecol; 1989 Jul; 41(7):349-52. PubMed ID: 2608204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical usefulness of SCC antigen for diagnosis of recurrent cervical squamous cancer].
    Umezawa S; Takeshima N; Shimizu Y; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):165-8. PubMed ID: 7706858
    [No Abstract]   [Full Text] [Related]  

  • 14. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SCC antigen].
    Kato H; Ogata H
    Nihon Rinsho; 1999 Dec; 57 Suppl():510-2. PubMed ID: 10778176
    [No Abstract]   [Full Text] [Related]  

  • 18. [Squamous cell carcinoma antigen--a useful tumor marker for gynecologic squamous cell cancers?].
    Neunteufel W; Tatra G; Reinthaller A; Bieglmayer C
    Gynakol Rundsch; 1988; 28 Suppl 2():201-2. PubMed ID: 3234918
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor markers and cervical carcinoma.
    Taccone W; Belli M; Riccio M
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):63-6. PubMed ID: 1965450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.